Potential Use of ctDNA and MRD in CRC

2022 West Oncology Conference | Gastrointestinal Cancers | Colorectal SessionПодробнее

Tie J (2017): Tracking bowel cancer in a vial of bloodПодробнее

The use of ctDNA in identifying post-surgical CRC residual disease statusПодробнее

GI ASCO 2020 Recap WebinarПодробнее

Role of ctDNA in MRDПодробнее

ctDNA as a novel biomarker for MRD in CRCПодробнее

Monitoring MRD by ctDNA in resectable CRCПодробнее

Managing patients with CRC using ctDNAПодробнее

Dr Weinberg on the Prognostic Use of ctDNA Testing in Resected CRCПодробнее

Dr. Overman on Potential Applications of ctDNA in Colorectal CancerПодробнее

ctDNA and MRD | 2023 Best of GI Cancer ConferenceПодробнее

Dr. Kasi on the Prognostic Value of ctDNA in CRCПодробнее

Potential role of ctDNA for early-stage breast cancerПодробнее

Dr. Nelson on the Future Utility of ctDNA in CRCПодробнее

Postsurgical ctDNA Surveillance in Locally Advanced CRCПодробнее

First real-world ctDNA analysis of oligometastic CRCПодробнее

The emerging role of ctDNA in cancer diagnosticsПодробнее

ctDNA and MRD—How, When, and on Who Do We Use It | Kristen Ciombor, MD | ESMO22 PennsylvaniaПодробнее

Dr. Bach on Examining ctDNA in CRCПодробнее

Dr. Armaghany on the Utility of ctDNA in CRCПодробнее

The emerging role of MRD in colorectal cancer decision makingПодробнее